titlesubmit dateissue date
Now showing items 1-5 of 5
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma
DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis
EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.